The Open Cardiovascular and Thoracic Surgery Journal

2012, 5 : 8-10
Published online 2012 February 17. DOI: 10.2174/1876533501205010008
Publisher ID: TOCTSJ-5-8

Vascular Site Hemostasis in Percutaneous Extracorporeal Membrane Oxygenation Therapy

Kathleen M. Lamb , Harrison T. Pitcher , Nicholas C. Cavarocchi and Hitoshi Hirose
Department of Surgery, Thomas Jefferson University Hospital, 1025 Walnut Street Room 605, Philadelphia, PA 19107, USA.

ABSTRACT

Bleeding is a well described complication of percutaneous extracorporeal membrane oxygenation support (ECMO). In an effort to prevent ongoing percutaneous-cannula blood loss, we tried multiple methods to achieve hemostasis and obtained the best results with QuikClot® Combat GauzeTM (Z-Medica Corp, Wallingford, CT). This product is made of kaolin, white alumina silicate clay, which initiates activation of the intrinsic clotting cascade. We reviewed our experience in 21 ECMO patients and found 5 patients who required 17 applications of QuikClot® Combat GauzeTM to percutaneous catheter insertion sites and demonstrated a significant reduction in both localized bleeding complications and the need for blood transfusion. QuikClot Combat GauzeTM, used for the dual purpose of a dressing and hemostatic agent, is a simple valuable method to control pericatheter bleeding in the ECMO population with demonstrated cost savings and clinical utility.